Author:
Guo Chen,Zhu Xichun,Yuan Haoyang,Liu Haoyu,Zhang Yu,Yin Tian,He Haibing,Gou Jingxin,Tang Xing
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference37 articles.
1. Bartsch V. Oral vinorelbine: pharmacology and results in the treatment of non-small cell lung cancer and breast cancer. Onkologie. 2006;29:1–28. https://doi.org/10.1159/000091889.
2. Gebbia V, Puozzo C. Oral versus intravenous vinorelbine: clinical safety profile. Expert Opin Drug Saf. 2005;4(5):915–28. https://doi.org/10.1517/14740338.4.5.915.
3. Lesueur P, Martel-Laffay I, Escande A, Kissel M, Locher C, Gervais R, et al. Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review. Expert Rev Anticancer Ther. 2018;18(11):1159–65. https://doi.org/10.1080/14737140.2018.1518714.
4. Urso R, Nencini C, Giorgi G, Fiaschii AI. Chemotherapy-induced myelosuppression by Vinorelbine: a comparison between different dose schedules by simulation. Eur Rev Med Pharmacol Sci. 2007;11(6):413–7.
5. Yang S-H, Lin C-C, Lin Z-Z, Tseng Y-L, Hong R-L. A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor. Invest New Drugs. 2012;30(1):282–9. https://doi.org/10.1007/s10637-010-9522-3.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献